CMPR Stock Analysis: Cimpress | NASDAQ
Specialty Business Services | NASDAQ, USA | Market Cap: 1.792m USD | 12M Return: 14.4% | IE00BKYC3F77 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.3M
Qual. Beats: 0
Rev. Trend: 97.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Its customer base spans small and medium-sized businesses, graphic designers, resellers, printers, associations, and individual consumers. The mass customization model combines web-based ordering and centralized production to deliver personalized products at scale, an approach that has become a defining feature of the modern commercial printing industry as digital and on-demand printing have largely displaced traditional offset runs.
- Vista segment revenue growth drives consolidated performance
- European currency headwinds pressure reported revenue and margins
- Refinancing of high-yield debt reduces interest expense burden
| Net Income: 95.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.36 > 1.0 |
| NWC/Revenue: -5.65% < 20% (prev -7.52%; Δ 1.87% < -1%) |
| CFO/TA 0.13 > 3% & CFO 284.5m > Net Income 95.9m |
| Net Debt (1.67b) to EBITDA (410.5m): 4.06 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.8m) vs 12m ago 4.21% < -2% |
| Gross Margin: 46.29% > 18% (prev 47.53%; Δ -1.24% > 0.5%) |
| Asset Turnover: 179.2% > 50% (prev 172.9%; Δ 6.28% > 0%) |
| Interest Coverage Ratio: 2.45 > 6 (EBIT TTM 258.6m / Interest Expense TTM 105.8m) |
| A: -0.10 (Total Current Assets 564.5m - Total Current Liabilities 775.6m) / Total Assets 2.20b |
| B: 0.13 (Retained Earnings 279.4m / Total Assets 2.20b) |
| C: 0.12 (EBIT TTM 258.6m / Avg Total Assets 2.09b) |
| D: -0.19 (Book Value of Equity -494.0m / Total Liabilities 2.60b) |
| Altman-Z'' = 0.42 = B |
| DSRI: 0.98 (Receivables 73.6m/68.3m, Revenue 3.74b/3.40b) |
| GMI: 1.03 (GM 47.53% / 46.29%) |
| AQI: 0.95 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.10 (Revenue 3.74b / 3.40b) |
| TATA: -0.09 (NI 95.9m - CFO 284.5m) / TA 2.20b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of October 15, 2026, the stock is trading at USD 73.44 with a total of 193,350 shares traded. Over the past week, the price has changed by -0.20%, over one month by -12.73%, over three months by -25.46% and over the past year by +14.43%.
Current recommended Stop Loss: 70.10 (which is 4.5% or 1.3 ATR below the current price).
Cimpress has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CMPR.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 114.5 | 55.9% |
P/E Trailing = 19.4169
P/E Forward = 16.9492
P/S = 0.4795
P/B = 27.9638
P/EG = 2.381
Revenue TTM = 3.74b USD
EBIT TTM = 258.6m USD
EBITDA TTM = 410.5m USD
Long Term Debt = 1.60b USD (from longTermDebt, last quarter)
Short Term Debt = 39.4m USD (from shortTermDebt, last quarter)
Debt = 1.92b USD (from shortLongTermDebtTotal, last quarter) + Leases 176.5m
Net Debt = 1.67b USD (calculated: Debt 1.92b - CCE 248.9m)
Enterprise Value = 3.46b USD (1.79b + Debt 1.92b - CCE 248.9m)
Interest Coverage Ratio = 2.45 (Ebit TTM 258.6m / Interest Expense TTM 105.8m)
EV/FCF = 20.71x (Enterprise Value 3.46b / FCF TTM 167.0m)
FCF Yield = 4.83% (FCF TTM 167.0m / Enterprise Value 3.46b)
FCF Margin = 4.47% (FCF TTM 167.0m / Revenue TTM 3.74b)
Net Margin = 2.57% (Net Income TTM 95.9m / Revenue TTM 3.74b)
Gross Margin = 46.29% ((Revenue TTM 3.74b - Cost of Revenue TTM 2.01b) / Revenue TTM)
Gross Margin QoQ = 45.50% (prev 46.17%)
Tobins Q-Ratio = 1.57 (Enterprise Value 3.46b / Total Assets 2.20b)
Interest Expense / Debt = 5.52% (Interest Expense 105.8m / Debt 1.92b)
Taxrate = 36.48% (55.8m / 152.9m)
NOPAT = 164.3m (EBIT 258.6m * (1 - 36.48%))
Current Ratio = 0.73 (Total Current Assets 564.5m / Total Current Liabilities 775.6m)
Debt / Equity = -3.88 (negative equity) (Debt 1.92b / totalStockholderEquity, last quarter -494.0m)
Debt / EBITDA = 4.06 (Net Debt 1.67b / EBITDA 410.5m)
Debt / FCF = 9.98 (Net Debt 1.67b / FCF TTM 167.0m)
Total Stockholder Equity = -530.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.60% (Net Income 95.9m / Total Assets 2.20b)
RoE = -18.09% (negative equity) (Net Income TTM 95.9m / Total Stockholder Equity -530.0m)
RoCE = 24.23% (EBIT 258.6m / Capital Employed (Equity -530.0m + L.T.Debt 1.60b))
RoIC = 12.84% (NOPAT 164.3m / Invested Capital 1.28b)
WACC = 6.40% (E(1.79b)/V(3.71b) * Re(9.49%) + D(1.92b)/V(3.71b) * Rd(5.52%) * (1-Tc(0.36)))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -47.21 | Cagr: -0.77%
[DCF] Terminal Value 74.72% ; FCFF base≈170.6m ; Y1≈164.0m ; Y5≈159.1m
[DCF] Fair Price = 34.16 (EV 2.50b - Net Debt 1.67b = Equity 831.8m / Shares 24.3m; r=8.35% [WACC [floored]]; 5y FCF grow -5.12% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.05 | # QB: 0
Revenue Correlation: 97.57 | Revenue CAGR: 5.87% | SUE: -0.03 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.81 | Chg30d=+0.00% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-12-31): EPS=2.05 | Chg30d=+0.00% | Revisions=+0% | Analysts=2
EPS current Year (2027-06-30): EPS=5.00 | Chg30d=+0.00% | Revisions=-40% | GrowthEPS=+31.9% | GrowthRev=+7.2%
EPS next Year (2028-06-30): EPS=7.67 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+53.5% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: -50% (up=0, down=3)